The molecular profiling of tumors has opened the door to more effective therapies adapted to the condition of each patient. However, this approach has posed new challenges to medical teams, who are re...
Read moreOrigo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led ...
Read moreLa revista Nature Communications publica hoy el estudio realizado por investigadores del Clínic-IDIBAPS, dentro de la convocatoria de salud de la Fundación "la Caixa", en el que han desarrollado y v...
Read moreScience is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the mo...
Read moreInvestigadores del Hospital Universitario Marqués de Valdecilla y de la Fundación Instituto de Investigación Marqués Valdecilla (IDIVAL) han colaborado en un trabajo que estudia la molécula GalNA...
Read moreEarly identification of the molecular characteristics of tumors in cancer patients is gaining increasing relevance in the development of anti-cancer therapies. Early molecular profiling influences the...
Read moreThis transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both c...
Read moreEl equipo de Otorrinolaringología ha realizado con éxito la primera laringectomía supraglótica, que aporta numerosas ventajas al paciente ya que es una intervención transoral sin incisiones (TORS...
Read moreInvestigadores del IDIBAPS coordinan un estudio que demuestra el potencial de una nueva estrategia antifibrótica en enfermedades hepáticas crónicas. Se trata del papel de una enzima involucrada en ...
Read moreRecent studies have found that some human cancer cells display a mutation bias where DNA that directly codes for proteins mutates at a different rate compared to DNA sequences which do not. It was hyp...
Read moreResearchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel te...
Read moreLa empresa ha conseguido 2,8 millones de euros del programa europeo EIC Accelerator, que apoya a compañías innovadoras, y ha cerrado una ronda de inversión por valor de 1,3 millones.
Read more